Multi-Cancer Blood Test Reduces Stage IV Diagnoses in Large Clinical Trial
Results from the NHS-Galleri study show a 26% reduction in metastatic cancer diagnoses by the third round of screening.
Read MorePosted by CLP Edit Staff | Jun 4, 2026 | Cancer, Molecular Diagnostics |
Results from the NHS-Galleri study show a 26% reduction in metastatic cancer diagnoses by the third round of screening.
Read MorePosted by CLP Edit Staff | Jun 2, 2026 | Diagnostic Technologies, Lab Management, Needles, Tubes, and Tourniquets |
Barriers to blood specimen collection in pediatric patients—especially those with sensory sensitivities—can delay diagnosis and care, according to Franchesca Kelly, PBT(ASCP), who says strategies to address access are urgently needed.
Read MorePosted by CLP Edit Staff | Jun 2, 2026 | Molecular Diagnostics |
The new 3B-NEO service uses whole exome and whole genome sequencing to identify risks for serious childhood-onset disorders before symptoms appear.
Read MorePosted by CLP Edit Staff | May 29, 2026 | Urinalysis & Toxicology |
The screening tool identifies specific molecules produced by gut bacteria to distinguish children with autism from typically developing peers.
Read MorePosted by CLP Edit Staff | May 28, 2026 | Company News, Lab Automation, Molecular Diagnostics |
The Callisto Sample Prep System application is optimized for the PromethION platform to support whole genome sequencing workflows.
Read More